Tetracycline and trimethoprim/sulfamethoxazole at clinical laboratory: Can they help to characterize Staphylococcus aureus carrying different SCCmec types?
Rev. Soc. Bras. Med. Trop
;
46(1): 100-102, Jan.-Feb. 2013. tab
Article
in English
| LILACS
| ID: lil-666803
ABSTRACT
INTRODUCTION:
Methicillin-resistant Staphylococcus aureus (MRSA) can be difficult to detect at the clinical practice.METHODS:
We analyzed 140 MRSA isolates from inpatients to correlate the antimicrobial susceptibility with the SCCmec types.RESULTS:
Type III (n = 63) isolates were more resistant to ciprofloxacin, clindamycin, cloramphenicol, erythromycin, gentamicin, and rifampin than type IV (n = 65) ones (p < 0.05). Moreover, type IV isolates were susceptible to tetracycline (100%) and trimethoprim/sulfamethoxazole (98%), while type III isolates presented resistance to them.CONCLUSIONS:
In regions where these SCCmec types are prevalent, the detection of specific resistant phenotypes could help to predict them, mainly when there are no technical conditions to SCCmec typing.
Search on Google
Index:
LILACS (Americas)
Main subject:
Tetracycline
/
Trimethoprim, Sulfamethoxazole Drug Combination
/
Drug Resistance, Multiple, Bacterial
/
Methicillin-Resistant Staphylococcus aureus
/
Anti-Bacterial Agents
Limits:
Humans
Language:
English
Journal:
Rev. Soc. Bras. Med. Trop
Journal subject:
Tropical Medicine
Year:
2013
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal do Rio de Janeiro/BR
Similar
MEDLINE
...
LILACS
LIS